Acromegaly and thyroid cancer: analysis of evolution in a series of patients

Autor: Karina Danilowicz, Soledad Sosa, Mariana Soledad Gonzalez Pernas, Elizabeth Bamberger, Sabrina Mara Diez, Patricia Fainstein-Day, Alejandra Furioso, Mariela Glerean, Mirtha Guitelman, Débora Katz, Nicole Lemaitre, Alicia Lowenstein, Mariela del Valle Luna, María Paz Martínez, Karina Miragaya, Daniel Moncet, María Victoria Ortuño, Analía Pignatta, Constanza Fernanda Ramacciotti, Adriana Reyes, Amelia Susana Rogozinski, Patricia Slavinsky, Julieta Tkatch, Fabián Pitoia

Publikováno v: Clinical Diabetes and Endocrinology, Vol 6, Iss 1, Pp 1-7 (2020)

Abstract Background Acromegaly is associated with higher morbidity and mortality mainly due to cardiovascular disease. Data on the incidence and evolution of thyroid cancer in acromegaly are controversial. Our objective was to describe the characteri

Externí odkaz: https://doaj.org/article/334a421f818f46339446b07084f9322b

Pegvisomant in acromegaly: a multicenter real-life study in Argentina

Autor: Natalia Ximena Garcia Basavilbaso, Maria Carolina Ballarino, Darío Bruera, Oscar D. Bruno, Alberto B. Chervin, Karina Danilowicz, Patricia Fainstein-Day, Silvina Gabriela Fidalgo, Adriana Frigeri, Mariela Glerean, Rodolfo Guelman, Gabriel Isaac, Debora Adela Katz, Pablo Knoblovits, Fabiana Librandi, Monica López Montes, Maria Susana Mallea-Gil, Marcos Manavela, Paula Mereshian, Daniel Moncet, Analia Pignatta, Amelia Rogozinsky, Laura R. Sago, Marisa Servidio, Monica Spezzi, Graciela Stalldecker, Julieta Tkatch, Nicolas Marcelo Vitale, Mirtha Guitelman

Publikováno v: Archives of Endocrinology and Metabolism, Vol 63, Iss 4, Pp 320-327

ABSTRACT Objective To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. Subjects and methods We retrospectively reviewed the clinical, horm

Externí odkaz: https://doaj.org/article/39ce9f9a76044f2fbe7a979e1fdb1177

Pegvisomant in acromegaly: a multicenter real-life study in Argentina

Autor: Analía Pignatta, Adriana Frigeri, Laura R. Sago, Natalia Garcia Basavilbaso, Marisa Servidio, Rodolfo Guelman, Nicolas Marcelo Vitale, Gabriel Isaac, Darío Bruera, Silvina Gabriela Fidalgo, Mirtha Guitelman, Oscar D. Bruno, Alberto Chervin, Paula Szafryk de Mereshian, Fabiana Librandi, Daniel Moncet, Marcos Manavela, Mariela Glerean, Monica Spezzi, Débora Katz, Pablo Knoblovits, Patricia Fainstein-Day, Julieta Tkatch, Graciela Stalldecker, Karina Danilowicz, Monica López Montes, Amelia Rogozinsky, Maria Carolina Ballarino, María Susana Mallea-Gil

Publikováno v: Archives of Endocrinology and Metabolism, Volume: 63, Issue: 4, Pages: 320-327, Published: 22 AUG 2019
Archives of Endocrinology and Metabolism, Vol 63, Iss 4, Pp 320-327
Archives of Endocrinology and Metabolism v.63 n.4 2019
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM

Objective To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. Subjects and methods We retrospectively reviewed the clinical, hormonal and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106aacc89fa47c7414d0565d361889c3
https://doi.org/10.20945/2359-3997000000160

SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours

Autor: John A. Crolla, Juan Pedro Martinez-Barbera, Mehul T. Dattani, Daniel Kelberman, KS Alatzoglou, Martin Roubicek, Maria Cristina Arriazu, Charles R. Buchanan, Daniel Moncet, Cynthia L. Andoniadou

Publikováno v: Human Mutation

SOX2 is an early developmental transcription factor and marker of stem cells that has recently been implicated in the development of the pituitary gland. Heterozygous SOX2 mutations have been described in patients with hypopituitarism and severe ocul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa10b151a5ddf875fb6677c8199f89ab
http://europepmc.org/articles/PMC3487182

Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing&'s syndrome Tratamiento con ketoconazol: Una alternativa eficaz para lograr el eucortisolismo en pacientes con síndrome de Cushing

Autor: Daniel Moncet, Daniel J. Morando, Fabián Pitoia, Silvia B. Katz, María A. Rossi, Oscar D. Bruno

Publikováno v: Medicina (Buenos Aires), Vol 67, Iss 1, Pp 26-31 (2007)

Cushing&'s syndrome (CS) is a serious condition requiring drug management in diverse clinical settings. Fifty four patients (44 females, 10 males) with CS, aged 14-63, received ketoconazole (KTZ) prior to surgery (n= 27), as complementary therapy aft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::09c741b1dd9c0204bb07c7a8bb5461e6
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000100004